y 27632 has been researched along with ag-490 in 3 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (ag-490) | Trials (ag-490) | Recent Studies (post-2010) (ag-490) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 732 | 2 | 322 |
Protein | Taxonomy | y 27632 (IC50) | ag-490 (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 1.9224 | |
Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 3.38 | |
large T antigen | Betapolyomavirus macacae | 14.61 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
Bao, LY; Chen, K; Dai, ZT; Gu, CJ; Guo, W; Huang, F; Li, H; Li, HH; Li, JP; Liao, XH; Wang, J; Xiang, Y; Zhang, HM; Zhang, TC; Zhang, ZJ | 1 |
3 other study(ies) available for y 27632 and ag-490
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
MKL-1 is a coactivator for STAT5b, the regulator of Treg cell development and function.
Topics: Amides; Base Sequence; Biomarkers; CD3 Complex; Cell Nucleus; Forkhead Transcription Factors; Humans; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Janus Kinase 3; Lymphocyte Count; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Protein Domains; Purpura, Thrombocytopenic, Idiopathic; Pyridines; rhoA GTP-Binding Protein; Serum Response Factor; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes, Regulatory; Trans-Activators; Tyrphostins | 2020 |